Skip to main content

Osteoporosis Management in Women Who Had a Fracture

CBE ID
0053
1.4 Project
Primary Care and Chronic Illness
Endorsed
Endorsement Status
Endorsed
1.1 New or Maintenance
Maintenance
E&M Cycle
Spring 2018
Is Under Review
No
Next Planned Maintenance Review
Primary Care and Chronic Illness Fall 2024
1.3 Measure Description

The percentage of women age 50-85 who suffered a fracture and who either had a bone mineral density test or received a prescription for a drug to treat osteoporosis.

    • 1.14 Numerator

      Patients who received either a bone mineral density test or a prescription for a drug to treat osteoporosis after a fracture occurs.

    • 1.15 Denominator

      Women who experienced a fracture, except fractures of the finger, toe, face or skull. Three denominator age strata are reported for this measure:
      Women age 50-64
      Women age 65-85
      Women age 50-85

    • Exclusions

      - Exclude women who had a bone mineral density test during the 24 months prior to the index fracture.
      - Exclude women who had a claim/encounter for osteoporosis treatment during 12 months prior to the index fracture.
      - Exclude women who received a dispensed prescription or had an active prescription to treat osteoporosis during the 12 months prior to the index fracture.
      - Exclude women who are enrolled in a Medicare Institutional Special Needs Plan (I-SNP) or living long-term in an institution any time during the measurement year.
      - Exclude women receiving hospice care during the measurement year.

    • Most Recent Endorsement Activity
      Endorsed Primary Care and Chronic Illness Spring Cycle 2018
      Initial Endorsement
      Last Updated
    • Steward
      National Committee for Quality Assurance
      Steward Organization Email
      [email protected]
      Steward Organization Copyright

      The performance measures and specifications were developed by and are owned by the National Committee for Quality Assurance (“NCQA”). The performance measures and specifications are not clinical guidelines and do not establish a standard of medical care. NCQA makes no representations, warranties, or endorsement about the quality of any organization or physician that uses or reports performance measures and NCQA has no liability to anyone who relies on such measures or specifications. NCQA holds a copyright in these materials and can rescind or alter these materials at any time. These materials may not be modified by anyone other than NCQA. Anyone desiring to use or reproduce the materials without modification for an internal, quality improvement non-commercial purpose may do so without obtaining any approval from NCQA. All other uses, including a commercial use and/or external reproduction, distribution and publication must be approved by NCQA and are subject to a license at the discretion of NCQA.
      ©2018 NCQA, all rights reserved.
      Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. NCQA disclaims all liability for use or accuracy of any coding contained in the specifications.

      Content reproduced with permission from HEDIS, Volume 2: Technical Specifications for Health Plans. To purchase copies of this publication, including the full measures and specifications, contact NCQA Customer Support at 888-275-7585 or visit www.ncqa.org/publications.